An industrial approach towards solid dosage development for first-in-human studies: Application of predictive science and lean principles

An industrial approach towards solid dosage development for first-in-human studies: Application of predictive science and lean principles

Publication: Drug Discov Today
Software: GastroPlus®

Tablet development is challenging during early clinical phases of drug discovery because of dose uncertainty, limited active pharmaceutical ingredient availability, and short lead times.

Bridging inhaled aerosol dosimetry to physiologically based pharmacokinetic modeling for toxicological assessment: nicotine delivery systems and beyond

Bridging inhaled aerosol dosimetry to physiologically based pharmacokinetic modeling for toxicological assessment: nicotine delivery systems and beyond

Publication: Crit Rev Toxicol
Software: GastroPlus®

One of the challenges for toxicological assessment of inhaled aerosols is to accurately predict their deposited and absorbed dose.

Physiologically Based Pharmacokinetic Model to Support Ophthalmic Suspension Product Development

Physiologically Based Pharmacokinetic Model to Support Ophthalmic Suspension Product Development

Publication: AAPS J
Software: GastroPlus®
Division: PBPK

FDA’s Orange Book lists 17 currently marketed active pharmaceutical ingredients (API) formulated within ophthalmic suspensions in which a majority has 90% or more of the API undissolved.

In Vitro Dissolution and in Silico Modeling Shortcuts in Bioequivalence Testing

In Vitro Dissolution and in Silico Modeling Shortcuts in Bioequivalence Testing

Publication: Pharmaceutics

To review in vitro testing and simulation platforms that are in current use to predict in vivo performances of generic products as well as other situations to provide evidence for biowaiver and support drug formulations development.

The Significance of Utilizing In Vitro Transfer Model and Media Selection to Study the Dissolution Performance of Weak Ionizable Bases: Investigation Using Saquinavir as a Model Drug

The Significance of Utilizing In Vitro Transfer Model and Media Selection to Study the Dissolution Performance of Weak Ionizable Bases: Investigation Using Saquinavir as a Model Drug

Publication: AAPS PharmSciTech
Software: GastroPlus®

This study investigated the dissolution behavior of BCS class II ionizable weak base Saquinavir and its mesylate salt in the multi-compartment transfer setup employing different composition of dissolution media.

Integrated phytochemical analysis based on UHPLC-LTQ–Orbitrap and network pharmacology approaches to explore the potential mechanism of Lycium ruthenicum Murr. for ameliorating Alzheimer’s disease

Integrated phytochemical analysis based on UHPLC-LTQ–Orbitrap and network pharmacology approaches to explore the potential mechanism of Lycium ruthenicum Murr. for ameliorating Alzheimer’s disease

Publication: Food & Function
Software: ADMET Predictor®

Based on compelling experimental and clinical evidence, the fruit of Lycium ruthenicum Murr. (LRM), a unique traditional Tibetan medicine...